Devices › Device types
FDA product code CEM · class 2 · Clinical Chemistry
Electrode, ion specific, potassium: medical device reports filed with FDA
1,010 reports carry this product code, 1996–2026; 19 brands with a page.
- 1,010
- reports with this product code
- 0% of all MAUDE reports
- 28
- reports, 12 months to August 2026
- 27 in the 12 months before
- 95%
- classified as malfunction
- 62.3% across all reports
- 0.4%
- classified as death, as reported
- 0.9% across all reports
Product code CEM is FDA's classification for "Electrode, ion specific, potassium" (clinical Chemistry panel), a class 2 device. 1,010 medical device reports carry this product code, 0% of the MAUDE database, from December 1996 to August 2026.
28 reports arrived in the 12 months to August 2026, close to the 27 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95%), injury (3.2%) and other (1.3%). 19 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| cobas 6000 c501 module | 258 | 194 | 0.1% | 99.1% |
| Cobas 6000 C501module | 86 | 0 | 0% | 99.4% |
| Cobas 6000 Core | 58 | 0 | 0% | 97.5% |
| cobas 6000 e601 module | 55 | 85 | 0% | 98.9% |
| COBAS 6000 C (501) Module | 35 | 129 | 0% | 99.5% |
| Architect C16000 System | 10 | 0 | 0.2% | 99.1% |
| i-STAT CG8+ Cartridge | 6 | 7 | 0% | 98% |
| Clinitek Status+ | 3 | 25 | 0% | 83.7% |
| Cobas E411 Disk System | 3 | 0 | 0% | 99.3% |
| Cobas 6000 E 601 Module | 2 | 0 | 0% | 99.7% |
| i-STAT CHEM8+ Cartridge | 2 | 28 | 0% | 99.3% |
| Unicel Dxc 800 Synchron Clinical System | 2 | 0 | 0% | 99.7% |
| Advia 1800 | 1 | 0 | 0% | 92.4% |
| Architect C8000 System | 1 | 0 | 0.1% | 97.1% |
| AU5800 Clinical Chemistry Analyzer | 1 | 69 | 0% | 96.6% |
| AU680 Clinical Chemistry Analyzer | 1 | 15 | 0.2% | 94.8% |
| cobas 8000 ISE 1800 Module | 1 | 141 | 0% | 99.7% |
| Unicel Dxc 800 Pro Synchron System | 1 | 0 | 0% | 95.9% |
| Vitros 250 Chemistry System | 1 | 0 | 0% | 100% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Roche Diagnostics | 568 | 56.2% |
| Ortho-Clinical Diagnostics | 50 | 5% |
| Siemens Healthcare Diagnostics - Glasgow | 21 | 2.1% |
| Abbott Point Of Care | 17 | 1.7% |
| Abbott Manufacturing | 10 | 1% |
| Nova Biomedical | 2 | 0.2% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Low test results | 357 | 35.3% |
| High test results | 269 | 26.6% |
| Incorrect or inadequate test results | 144 | 14.3% |
| Incorrect, inadequate or imprecise result or readings | 53 | 5.2% |
| Leak/splashthe device leaked | 24 | 2.4% |
| Fluid/blood leak | 21 | 2.1% |
| Non reproducible results | 19 | 1.9% |
| Nonstandard device | 17 | 1.7% |
| Low readingsreadings were too low | 16 | 1.6% |
| Insufficient device problem information | 13 | 1.3% |
| Mechanical problema mechanical problem | 12 | 1.2% |
| High readingsreadings were too high | 11 | 1.1% |
| Computer software problema software problem | 8 | 0.8% |
| False positive result | 8 | 0.8% |
| Output problem | 8 | 0.8% |
| Malfunction | 6 | 0.6% |
| Calibration problem | 5 | 0.5% |
| Output, low | 5 | 0.5% |
| False negative result | 4 | 0.4% |
| Incorrect measurementthe device measured wrongly | 4 | 0.4% |
Questions about electrode, ion specific, potassium reports
What is product code CEM?
FDA's classification code for "Electrode, ion specific, potassium", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,010 reports through August 2026, 28 of them in the latest 12 months.
Which brands appear most often?
cobas 6000 c501 module (258), Cobas 6000 C501module (86), Cobas 6000 Core (58), cobas 6000 e601 module (55) and COBAS 6000 C (501) Module (35). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.